Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

As HIV care continues to evolve, 2-drug regimens are emerging as a key strategy to balance efficacy with long-term ...

Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

Tom Perrault, right, a longtime SF resident and activist, took part in a novel HIV study from UCSF. (Courtesy of Tom Perrault ...

Add Yahoo as a preferred source to see more of our stories on Google. Medications have kept Tori Samuel’s HIV at bay for decades. The part-time worker from Ocala, Florida, has thrived, marrying her ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade, since the ...

A man in Norway has achieved long-term HIV remission after a stem cell transplant from his brother. Researchers say rare ...

After over a decade with HIV, a Norwegian man received a surprise through a stem cell donation from his sibling. The gifted ...

A study by Emory University found that investment in antiretroviral therapy (ART) has saved Georgia over $100 billion over 25 years, prevented 57,885 new HIV cases and 36,921 HIV-related deaths, and ...

The AIDS Healthcare Foundation is criticizing Gilead Sciences over the cost of HIV medications. Advocates warn that high drug ...

Leading sexual health charities have rebuked Nigel Farage ’s comments on HIV, warning that denying access to medication ...